Normal physiology and HIV pathophysiology of human T-cell dynamics

di Richman, Douglas D.
Pubblicazione 2000

Introduction: challenges to finding a cure for HIV infection

di Richman, Douglas D.
Pubblicazione 2011

Antiviral Drug Discovery To Address the COVID-19 Pandemic

di Richman, Douglas D.
Pubblicato in mBio (2020)

COVID-19 vaccines: implementation, limitations and opportunities

di Richman, Douglas D.
Pubblicato in Glob Health Med (2021)

Minority Variants of Drug-Resistant HIV

di Gianella, Sara, Richman, Douglas D.
Pubblicazione 2010

Measuring the latent reservoir in vivo

di Massanella, Marta, Richman, Douglas D.
Pubblicato in J Clin Invest (2016)

Antiviral Therapy

di Richman, Douglas D., Nathanson, Neal
Pubblicato in Viral Pathogenesis (2016)

New assays for monitoring residual HIV burden in effectively treated individuals

di Strain, Matthew C., Richman, Douglas D.
Pubblicazione 2013

Rates of emergence of HIV drug resistance in resource-limited settings: a systematic review

di Stadeli, Kathryn M, Richman, Douglas D
Pubblicato in Antivir Ther (2012)

Editorial overview: Antivirals and resistance: Advances and challenges ahead

di Menéndez-Arias, Luis, Richman, Douglas D
Pubblicato in Curr Opin Virol (2014)

CD40 ligand (CD154) stimulation of macrophages to produce HIV-1-suppressive β-chemokines

di Kornbluth, Richard S., Kee, Kristin, Richman, Douglas D.
Pubblicazione 1998

Molecular and Cellular Analysis of Human Immunodeficiency Virus-Induced Apoptosis in Lymphoblastoid T-Cell-Line-Expressing Wild-Type and Mutated CD4 Receptors

di Moutouh, Laure, Estaquier, Jérôme, Richman, Douglas D., Corbeil, Jacques
Pubblicazione 1998

Preferential replication of HIV-1 in the CD45RO memory cell subset of primary CD4 lymphocytes in vitro

di Spina, Celsa A., Prince, Harry E., Richman, Douglas D.
Pubblicazione 2000

Rapid evolution of the neutralizing antibody response to HIV type 1 infection

di Richman, Douglas D., Wrin, Terri, Little, Susan J., Petropoulos, Christos J.
Pubblicazione 2003

Use of temperature-sensitive mutants of influenza A virus as live virus vaccine strains. Evaluation in laboratory animals, adults and children

di Murphy, Brian R., Richman, Douglas D., Spring, Susan B., Chanock, Robert M.
Pubblicazione 1976

A Synthetic Bivalent Ligand of CXCR4 Inhibits HIV Infection

di Xu, Yan, Duggineni, Srinivas, Espitia, Stephen, Richman, Douglas D., An, Jing, Huang, Ziwei
Pubblicazione 2013

Antibody Response to Achromobacter xylosoxidans during HIV Infection Is Associated with Lower CD4 Levels and Increased Lymphocyte Activation

di Tatro, Erick T., Purnajo, Intan, Richman, Douglas D., Smith, Davey M., Gianella, Sara
Pubblicazione 2014

Evaluation of a Highly Sensitive Qualitative Human Immunodeficiency Virus Type 1 (HIV-1) RNA Assay for Detection of HIV-1 Suppression

di Nugent, C. Thomas, Nodelman, Vladislav, Giachetti, Cristina, Richman, Douglas D., Looney, David J.
Pubblicazione 2009

Quantification of Total and 2-LTR (Long terminal repeat) HIV DNA, HIV RNA and Herpesvirus DNA in PBMCs

di Massanella, Marta, Gianella, Sara, Lada, Steven M., Richman, Douglas D., Strain, Matthew C.
Pubblicato in Bio Protoc (2015)

The Efficiency of Single Genome Amplification and Sequencing is Improved by Quantitation and Use of a Bioinformatics Tool

di Butler, David M., Pacold, Mary E., Jordan, Parris S., Richman, Douglas D., Smith, Davey M.
Pubblicazione 2009